About

The HCV World CAB included a broad range of activists, including people with HCV, people who inject drugs, people living with HIV, representatives from non-governmental organizations and regional and global advocacy networks, and clinicians and researchers.

The HCV World CAB met with pharmaceutical and diagnostics companies that produce HCV treatment (branded and generics) and tests to understand their access, licensing, and pricing strategies, particularly in high-burden, low- and middle-income countries.